Syngene's inspection concluded successfully with zero observations, no Form 483 issued, and a 'no action indicated' classification.

• The facility is fully compliant with regulations, and no regulatory violations were noted during the audit.
• No Form 483 issued, indicating no formal FDA observations or corrective actions required.
• Syngene reaffirms its commitment to high standards and global regulatory compliance in all operations.